5Wu J,Zhu Y,Jiang Y,Cao Y. Effects of mefformin and ethinyl estradiol-cyproterone acetate on clinical,endocrine and metabohc factors in women with polycystic ovary syndrome[J]. Gynecol Endociimol,2008,24 (7) : 392-398. 被引量：1
6Neumann F. Pharmacological aspects of cyproterone acetate. In:Schindler AE,ed. Antiandrogen-estrogen therapy for signs of androgenization [M]. Berlin: New York Walter de Gruyter, 1987 : 23-40. 被引量：1
7Jing Z,Liang-ZHi X,Tai-Xuang W,et al. The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome:an updated systematic review[J]. Gynecol Endocrinol, 2008,24(10) : 590-600. 被引量：1
8Mitkov M,Pehlivanov B,Terzieva D. Combined use of mefformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome[J]. Eur J Obstet Gynecol Reprod Biol, 2005,118 (2) : 209-213. 被引量：1
